Senior Director
Merck & Co.
Kenilworth, New Jersey
Nicole completed a B.S. in Biology, with a biotechnology concentration at the University of Delaware and went on to complete a Ph.D. in synthetic organic chemistry at the University of California, Santa Cruz. Afterwards, she joined the Discovery Pharmaceutical Sciences department at Merck where she contributed to the nomination of multiple development compounds, implemented a Fixed Dose Combination workflow for the Discovery space and led a novel excipient evaluation team. In 2018, Nicole transitioned to the Sterile and Specialty Products development team and is currently a Director of large molecule formulation with a focus on the oncology pipeline. She is currently co-leading a multidepartment innovation team focused on understanding all aspects of subcutaneous delivery of biologics. External to Merck, Nicole has been an active member of the IQ Consortium and is currently the co-chair of the Accelerated Drug Development Working Group. She is also a co-chair of the Immunogenicity and member of the Clinical Trial Strategy sub-teams of the SC Consortium. Finally, Nicole is an active member of the AAPS community and previously served as the Excipient Focus Group Chair and currently serves in the Global Health Community.
Disclosure information not submitted.
Monday, October 17, 2022
10:30 AM – 11:30 AM ET